Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1% Market Closed
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Interest Income Expense Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Interest Income Expense
-€20k
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Interest Income Expense
-$21.7m
CAGR 3-Years
-134%
CAGR 5-Years
-114%
CAGR 10-Years
-80%
Galapagos NV
AEX:GLPG
Interest Income Expense
€248.1m
CAGR 3-Years
N/A
CAGR 5-Years
88%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Interest Income Expense
-€4.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Interest Income Expense?
Interest Income Expense
-20k EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Interest Income Expense amounts to -20k EUR.

What is Celyad Oncology SA's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
49%

Over the last year, the Interest Income Expense growth was 31%. The average annual Interest Income Expense growth rates for Celyad Oncology SA have been 49% over the past three years .

Back to Top